608 related articles for article (PubMed ID: 18463684)
1. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
[TBL] [Abstract][Full Text] [Related]
2. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways.
Zhang Q; Kelly AP; Wang L; French SW; Tang X; Duong HS; Messadi DV; Le AD
J Invest Dermatol; 2006 Dec; 126(12):2607-13. PubMed ID: 16841034
[TBL] [Abstract][Full Text] [Related]
3. Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration.
Lim CP; Phan TT; Lim IJ; Cao X
Oncogene; 2006 Aug; 25(39):5416-25. PubMed ID: 16619044
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
[TBL] [Abstract][Full Text] [Related]
5. Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways.
Song J; Xu H; Lu Q; Xu Z; Bian D; Xia Y; Wei Z; Gong Z; Dai Y
Burns; 2012 Aug; 38(5):677-84. PubMed ID: 22360962
[TBL] [Abstract][Full Text] [Related]
6. Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions.
Zhang Z; Nie F; Kang C; Chen B; Qin Z; Ma J; Ma Y; Zhao X
Int J Mol Med; 2014 Jul; 34(1):253-61. PubMed ID: 24788198
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
8. CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2.
Tu T; Huang J; Lin M; Gao Z; Wu X; Zhang W; Zhou G; Wang W; Liu W
Int J Mol Med; 2019 Nov; 44(5):1789-1800. PubMed ID: 31545402
[TBL] [Abstract][Full Text] [Related]
9. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
10. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.
Nagar H; Kim S; Lee I; Kim S; Choi SJ; Piao S; Jeon BH; Oh SH; Kim CS
Sci Rep; 2021 Jan; 11(1):500. PubMed ID: 33436666
[TBL] [Abstract][Full Text] [Related]
13. Gallic acid inhibits fibroblast growth and migration in keloids through the AKT/ERK signaling pathway.
Wang X; Liu K; Ruan M; Yang J; Gao Z
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1114-1120. PubMed ID: 30265275
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn.
Kim JA; Formoso G; Li Y; Potenza MA; Marasciulo FL; Montagnani M; Quon MJ
J Biol Chem; 2007 May; 282(18):13736-45. PubMed ID: 17363366
[TBL] [Abstract][Full Text] [Related]
15. Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids.
Lim IJ; Phan TT; Tan EK; Nguyen TT; Tran E; Longaker MT; Song C; Lee ST; Huynh HT
J Biol Chem; 2003 Oct; 278(42):40851-8. PubMed ID: 12907681
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
[TBL] [Abstract][Full Text] [Related]
18. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
Lv W; Wu M; Ren Y; Luo X; Hu W; Zhang Q; Wu Y
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200804
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.
Daian T; Ohtsuru A; Rogounovitch T; Ishihara H; Hirano A; Akiyama-Uchida Y; Saenko V; Fujii T; Yamashita S
J Invest Dermatol; 2003 Jun; 120(6):956-62. PubMed ID: 12787120
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Enjoji M; Kobayashi N; Nakamuta M
J Lab Clin Med; 2005 Jun; 145(6):316-22. PubMed ID: 15976760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
